Antiviral drug remdesivir can now be used to treat seriously ill Covid-19 patients in Singapore outside of clinical trials, after the Health Sciences Authority granted conditional approval to drugmaker Gilead Sciences. The conditional approval requires Gilead to collect the relevant safety data and to monitor the use of the drug. The approval was obtained in less than three weeks. Remdesivir was previously available in the country only through clinical trials.
Read full article here (internet required).
Subscribe to our mailing list to get the updates to your email inbox...